Riley Hospital steps up statewide push
New President Matthew Cook’s job is to build out a system that will help get physician referrals across the state to help fill Riley’s 385 beds.
Health Care & Insurance
Articles
Federal judge blocks Indiana abortion law before deadline
A federal judge blocked a new Indiana law Thursday that bans abortions sought because of a fetus' genetic abnormalities or because of its race, sex or ancestry. The law was to take effect Friday.
Anthem reportedly faces regulator skepticism that Cigna deal can work
The U.S. Justice Department has told Anthem Inc. that the insurer’s planned takeover of Cigna Corp. threatens competition and probably can’t be fixed by selling parts of their businesses, according to a person familiar with the matter.
Lilly stock rises after FDA panel backs new Jardiance label
A hot-selling drug for diabetes sold by Eli Lilly and Co. and a co-partner just got another potential boost, as a government panel narrowly recommended that the companies should be allowed to claim that the drug cuts the risk of cardiovascular death.
Anthem denies report about Cigna merger, says deal still ‘compelling’
Indianapolis-based health insurer Anthem Inc. said it is not in discussions with Cigna Corp. to end their planned $48 billion merger, as speculation about the health-insurance deal’s fate mounts.
Groups unsure whether ruling affects Indiana abortion laws
Groups on both sides of the debate say they're reviewing the U.S. Supreme Court ruling against Texas' regulation of abortion clinics to see whether it could have an impact on similar Indiana laws.
Embattled ITT winds down nursing program at 3 Indiana campuses
The state warned the institution about low passing rates earlier this year and asked for a “plan of correction”—the first step that could lead to a loss of state accreditation.
Anthem faces showdown with antitrust cops in bid for Cigna
The health insurers are set to meet Friday with the Justice Department’s No. 3 official, a critical moment as the government makes its decision about whether to approve or block the $48 billion deal.
CEO Ellis resigns after 20 years at struggling drug firm Endocyte
The West Lafayette-based company has named CFO and COO Mike Sherman as new CEO and president, but did not give a reason for the abrupt change in leadership.
More jitters over the Anthem-Cigna deal
Federal regulators are giving the proposed $48 billion merger between health insurers Anthem Inc. and Cigna Corp a hard look, and some analysts are hedging their bets.
Study: Docs who get free meals pick branded drugs more
Doctors who accept free meals from the pharmaceutical industry are more likely to prescribe certain branded drugs to Medicare patients than generics, according to a study published Monday.
IU to hire 40 faculty, spend up to $120M on new initiative
The money will be awarded from IU’s Grand Challenges Program, a new push that is designed to tackle “major and large-scale problems facing humanity” that can only be addressed by multidisciplinary research teams.
Endowment’s rising assets give Indy competitive edge
After a long swoon, the Lilly Endowment is packing an increasing philanthropic punch. Assets climbed to $11.8 billion in 2015, the fifth straight year they rose.
California insurance chief urges block of Anthem-Cigna merger
California Insurance Commissioner Dave Jones on Thursday called the deal “anti-competitive” and said it would hurt consumers, businesses and the state’s health insurance market.
Biotech firm lands funding for cancer targeting
Animated Dynamics Inc. has raised $1.7 million in early funding to help it get its technology to market.
Study predicts rising Obamacare premiums in 2017
Premiums for popular low-cost medical plans under the federal health care law are expected to go up an average of 11 percent next year, says a new study. But not in Indianapolis.
Indiana gains ground in Fortune 500 amid shuffle among elite
Indianapolis-based Simon Property Group Inc. and Warsaw’s Zimmer Biomet Holdings vaulted back among the top 500 this year, while local oil refiner Calumet Specialty Products Partners plummeted.
Troubled home health care provider Nightingale to sell itself
One of Indiana’s largest home health care providers, facing allegations that it put patients in immediate jeopardy, has agreed to be acquired by a competing company in a deal that could be worth as much as $3 million.
Merck, Pfizer double size of diabetes drug study to catch rivals
The competition heated up in the $71.5 billion global diabetes market last year after Indianapolis-based Eli Lilly’s and Boehringer Ingelheim’s Jardiance unexpectedly reduced the risk of heart attacks, strokes and deaths in a study.
New federal rules limit value of workplace wellness programs
The EEOC has decided that wellness programs must be voluntary and the associated incentives or discounts can’t exceed more than 30 percent of the cost of the employees’ health coverage.